Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 8.63% is 14% below its 5-year average of 10.00%, around the middle of its 5-year range (3.83%–16.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 67.79% above its 12-month average of 5.14%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): 8.63%.
RETURN ON EQUITY (ROE)
8.63%
RETURN ON EQUITY (ROE) AVG TTM
5.14%
RETURN ON EQUITY (ROE) AVG 3Y
7.95%
RETURN ON EQUITY (ROE) AVG 5Y
10.00%
RETURN ON EQUITY (ROE) AVG 10Y
10.53%
RETURN ON EQUITY (ROE) AVG 15Y
12.06%
RETURN ON EQUITY (ROE) AVG 20Y
14.36%
CURRENT VS TTM AVG
+67.79%
CURRENT VS 3Y AVG
+8.50%
CURRENT VS 5Y AVG
-13.73%
CURRENT VS 10Y AVG
-18.07%
CURRENT VS 15Y AVG
-28.47%
CURRENT VS 20Y AVG
-39.94%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-33.69%
vs the sector median at left
Bio-Techne Corporation
Market Cap
$11.37B
Return on Equity (ROE)
8.63%
TTM Avg
5.14%
3Y Avg
7.95%
5Y Avg
10.00%
Market Cap
$11.46B
Return on Equity (ROE)
N/A
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$10.83B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$10.80B
Return on Equity (ROE)
6.85%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
Market Cap
$12.08B
Return on Equity (ROE)
-17.13%
TTM Avg
-12.46%
3Y Avg
-8.76%
5Y Avg
-1.37%
Market Cap
$10.51B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
Market Cap
$12.25B
Return on Equity (ROE)
23.91%
TTM Avg
22.63%
3Y Avg
21.83%
5Y Avg
21.13%
Market Cap
$10.26B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$10.21B
Return on Equity (ROE)
15.51%
TTM Avg
15.81%
3Y Avg
15.92%
5Y Avg
17.27%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Techne Corporation (TECH) | $11.37B | 8.63% | 5.14% | 7.95% | 10.00% |
| DaVita Inc. (DVA)vs › | $11.46B | N/A | 329.18% | 200.63% | 164.66% |
| Universal Health Services, Inc. (UHS)vs › | $10.83B | 20.31% | 18.80% | 15.17% | 15.31% |
| The Cooper Companies, Inc. (COO)vs › | $10.80B | 6.85% | 4.70% | 4.67% | 11.22% |
| Baxter International Inc. (BAX)vs › | $12.08B | -17.13% | -12.46% | -8.76% | -1.37% |
| Align Technology, Inc. (ALGN)vs › | $10.51B | 9.77% | 10.54% | 10.84% | 19.93% |
| Encompass Health Corporation (EHC)vs › | $12.25B | 23.91% | 22.63% | 21.83% | 21.13% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.26B | 3.10% | -8.94% | -15.72% | 1.14% |
| The Ensign Group, Inc. (ENSG)vs › | $10.21B | 15.51% | 15.81% | 15.92% | 17.27% |
| Penumbra, Inc. (PEN)vs › | $12.56B | 10.49% | 6.83% | 5.29% | 3.21% |
ROE
8.6%
ROA
7.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 8.63% |
| 2026-03-31 | 5.25% |
| 2025-12-31 | 4.03% |
| 2025-09-30 | 3.97% |
| 2025-06-30 | 3.83% |
| 2025-03-31 | 6.52% |
| 2024-12-31 | 7.61% |
| 2024-09-30 | 7.05% |
| 2024-06-30 | 8.13% |
| 2024-03-31 | 10.08% |
| 2023-12-31 | 11.42% |
| 2023-09-30 | 12.35% |
| 2023-06-30 | 14.51% |
| 2023-03-31 | 14.36% |
| 2022-12-31 | 14.33% |
| 2022-09-30 | 16.67% |
| 2022-06-30 | 15.99% |
| 2022-03-31 | 13.15% |
| 2021-12-31 | 12.36% |
| 2021-09-30 | 10.77% |
| 2021-06-30 | 8.98% |
| 2021-03-31 | 11.97% |
| 2020-12-31 | 11.50% |
| 2020-09-30 | 17.25% |
| 2020-06-30 | 16.60% |
| 2020-03-31 | 14.47% |
| 2019-12-31 | 14.75% |
| 2019-09-30 | 7.93% |
| 2019-06-30 | 8.24% |
| 2019-03-31 | 10.51% |
| 2018-12-31 | 8.72% |
| 2018-09-30 | 11.44% |
| 2018-06-30 | 11.62% |
| 2018-03-31 | 10.70% |
| 2017-12-31 | 11.52% |
| 2017-09-30 | 7.54% |
| 2017-06-30 | 7.66% |
| 2017-03-31 | 7.67% |
| 2016-12-31 | 8.82% |
| 2016-09-30 | 10.95% |
| 2016-06-30 | 11.88% |
| 2016-03-31 | 12.33% |
| 2015-12-31 | 11.58% |
| 2015-09-30 | 12.71% |
| 2015-06-30 | 12.72% |
| 2015-03-31 | 13.20% |
| 2014-12-31 | 14.08% |
| 2014-09-30 | 13.54% |
| 2014-06-30 | 13.95% |
| 2014-03-31 | 14.48% |
| 2013-12-31 | 15.23% |
| 2013-09-30 | 15.73% |
| 2013-06-30 | 15.26% |
| 2013-03-31 | 15.48% |
| 2012-12-31 | 15.84% |
| 2012-09-30 | 16.23% |
| 2012-06-30 | 16.66% |
| 2012-03-31 | 17.60% |
| 2011-12-31 | 18.87% |
| 2011-09-30 | 19.25% |
| 2011-06-30 | 19.16% |
| 2011-03-31 | 19.40% |
| 2010-12-31 | 20.52% |
| 2010-09-30 | 20.89% |
| 2010-06-30 | 21.88% |
| 2010-03-31 | 21.76% |
| 2009-12-31 | 21.39% |
| 2009-09-30 | 21.96% |
| 2009-06-30 | 23.06% |
| 2009-03-31 | 25.09% |
| 2008-12-31 | 25.94% |
| 2008-09-30 | 22.33% |
| 2008-06-30 | 21.26% |
| 2008-03-31 | 21.20% |
| 2007-12-31 | 19.97% |
| 2007-09-30 | 18.99% |
| 2007-06-30 | 19.45% |
| 2007-03-31 | 19.85% |
| 2006-12-31 | 20.27% |
| 2006-09-30 | 21.01% |
| 2006-06-30 | 21.55% |
| 2006-03-31 | 22.89% |
| 2005-12-31 | 24.88% |
| 2005-09-30 | 23.56% |
| 2005-06-30 | 24.69% |
| 2005-03-31 | 24.74% |
| 2004-12-31 | 17.19% |
| 2004-09-30 | 17.43% |
| 2004-06-30 | 17.80% |
| 2004-03-31 | 18.43% |
| 2003-12-31 | 18.80% |
| 2003-09-30 | 18.92% |
| 2003-06-30 | 19.19% |
